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This study demonstrates a critical role forN-methyla-
tion in cyclosporin biosynthesis and maintenance
of the biologically active cyclosporin conformation.
The structural requirements for the AdoMet binding
to CySyn were defined. N-methylation of specific
amide positions in the cyclosporin backbone is
critical for the complete assembly and cyclization
of the cyclosporin peptide. A maximum of two
desmethyl positions is tolerated before peptide
assembly stalls. Subinhibitory concentrations of
AdoMet analogs directed peptide assembly towards
cyclosporins with less than seven N-methylated
amide bonds. Molecular modeling and nuclear
magnetic resonance analyses indicate thatN-methyl-
ation of specific amide bond positions in the cyclo-
sporin backbone is mandatory for the formation
of a product-like conformation and recognition by
the acceptor site of the downstream peptide bond
forming C-domain.
INTRODUCTION
Many peptide secondarymetabolites of microbial origin possess
clinically useful pharmacological activities due to their expanded
structural spectrum of nonproteinogenic amino- and hydroxy-
acid monomeric units, together with unique structural modifica-
tions (Gru¨newald and Marahiel, 2006; Konz and Marahiel, 1999;
Velkov and Lawen, 2003b; Walsh, 2004; Walsh et al., 2001). The
enormous structural and functional diversity of these low-molec-
ular weight peptides is attributable to their mode of biosynthesis.
Peptide secondary metabolites are assembled nonribosomally
by multifunctional modular enzymes, termed nonribosomal
peptide synthetases (NRPS) (Grunewald and Marahiel, 2006;
Konz and Marahiel, 1999; Velkov and Lawen, 2003b; Walsh,
2004; Walsh et al., 2001). In addition to their ability to utilize
a broad spectrum of proteinogenic and non-proteinogenic
monomeric units, NRPS introduce further structural diversity
into their products via auxiliary modifying functions that reside464 Chemistry & Biology 18, 464–475, April 22, 2011 ª2011 Elsevierin either externally associated or integral enzyme activities
(Gru¨newald and Marahiel, 2006; Konz and Marahiel, 1999;
Velkov and Lawen, 2003b; Walsh, 2004; Walsh et al., 2001). Inte-
gral tailoring domains, embedded within the modular assembly
line, act in cis to modify the peptide chain during elongation
(Konz and Marahiel, 1999; Velkov and Lawen, 2003b; Walsh
et al., 2001). External enzyme species act in trans via protein-
protein interactions with the synthetase while intermediates are
still covalently tethered, or postassembly, after release (Konz
and Marahiel, 1999; Walsh et al., 2001). Auxiliary enzymes that
catalyze modification reactions such asmethylations, glycosyla-
tions, halogenations, epimerizations, and heterocyclizations,
have been documented (Gru¨newald and Marahiel, 2006; Konz
and Marahiel, 1999; Vaillancourt et al., 2005; Velkov and Lawen,
2003b; Walsh, 2004; Walsh et al., 2001). The understanding of
these tailoring functions is of great relevance because the struc-
tural modifications they introduce are essential for the biological
activities of the natural products. Moreover, the exploitation of
these tailoring enzymes is of considerable utility in the synthesis
of structural variants of therapeutic natural products (Gru¨newald
andMarahiel, 2006; Kohli et al., 2001, 2002; Lin andWalsh, 2004;
Mahlert et al., 2005; Oberthu¨r et al., 2005; Trauger et al., 2000;
Vaillancourt et al., 2005; Velkov and Lawen, 2003b).
A characteristic property of many peptides of non-ribosomal
origin is the methylation of their backbone, including their amide
nitrogens (Mahlert et al., 2005; Miller et al., 2001, 2002; Patel and
Walsh, 2001; Velkov and Lawen, 2003b;Welker and von Do¨hren,
2006). An example of an N-methylated non-ribosomal peptide is
the cyclic undecapeptide cyclosporin A (CsA) (see Figure S1A
available online). CsA exhibits potent immunosuppressive
bioactivity and is in clinical use worldwide for the treatment of
allograft rejection (Borel et al., 1996). In CsA, 7 of the 11 amino
acid amide nitrogens are N-methylated (positions 1, 3, 4, 6, 9,
10, and 11). The undecapeptide cyclosporin backbone is
assembled in an assembly line fashion on the multifunctional
protein thiotemplate cyclosporin synthetase (CySyn) (Dittmann
et al., 1994; Velkov and Lawen, 2003b). The presence of func-
tional N-methyltransferase (N-MTase) activity in the CySyn
polypeptide was first demonstrated by photoaffinity labeling
with S-adenosyl-L-[methyl-14C]methionine and by the ability of
the purified enzyme to transfer the sulfonium methyl group from
S-adenosyl-L-methionine (AdoMet) to CsA (Lawen and Zocher,
1990; Velkov and Lawen, 2003a).Ltd All rights reserved
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sisting of a single 1.7 MDa polypeptide capable of catalyzing
a total of 40 partial reaction steps in the synthesis of CsA. The
CySyn polypeptide can be divided into eleven semi-autonomous
modular units, which are composed of homologous NRPS func-
tional domains responsible for the activation, modification, and
polymerization of the constituent amino acids of CsA (Velkov
and Lawen, 2003b;Weber et al., 1994). Themodular architecture
of CySyn conforms to an iterative organization such that the
amino acid sequence of the peptide product is colinear with
the order of the protein modules. The fundamental modular
unit consists of catalytic domains responsible for substrate
amino acid activation (A-domain), a peptidyl carrier protein
(PCP) domain that acts to translocate the 40-phosphopante-
theine (40-Ppant) covalently tethered peptidyl chain intermediate
between modular active sites, and a condensation (C-domain)
responsible for amide bond formation. CySyn contains four
(C)-(A)-(PCP) modules (modules 1, 6, 9, 11) and seven modules
that display an additional 430 amino acidN-MTase domain insert
between the A- and PCP-domains (modules 2, 3, 4, 5, 7, 8, 10),
presenting a modular domain order of (C)-(A)-(N-MTase)-(PCP)
(Figure S1B). N-methylation takes place before peptide bond
formation where these integral N-MTase domains catalyze the
transfer of the S-methyl group of AdoMet to the amide nitrogen
of the thioiesterfied amino acid, releasing S-adenosyl-L-homo-
cysteine as a reaction product (Dittmann et al., 1990; Lawen
and Zocher, 1990; Velkov and Lawen, 2003a).
Presently very little is known about the selectivity of the
AdoMet binding sites and the steric course of N-methyltransfer
in NRPS systems. This work provides an insight into the chemi-
cal selectivity of the AdoMet binding site(s) and the effects of
inhibitory cofactor analogs on cyclosporin biosynthesis.
RESULTS AND DISCUSSION
Structural Requirements for Cofactor Binding
to the N-MTase Centers of CySyn
The cofactor selectivity of the AdoMet binding pockets of
CySyn was assessed by screening a number of natural and
synthetic AdoMet analogs for inhibition of N-MTase activity
and photoaffinity labeling with [14C-methyl]AdoMet (Figure 1A;
Table S1). It should be noted that the radiolabel N-MTase
activity assay is a measure of N-methylation of the final
enzymatic product, CsA. Therefore, in addition to the contribu-
tion of the N-MTase domains, the assay is also dependent on
the perpetual contribution from the A-, PCP-, and C-domains
from each module. S-adenosyl-L-homocysteine (AdoHcy), sine-
fungin, and S-adenosyl-L-ethionine (AdoEth) were the only
compounds found to act as potent inhibitors. IC50 measure-
ments indicated an inhibitory efficacy in decreasing order of
AdoHcy > sinefungin > AdoEth. The N-MTase binding centers
appear to be stereo-selective for the L-isomer of AdoHcy as
the D-isomer was not inhibitory. The AdoMet precursor methio-
nine and the amino acid components of each of the inhibitory
analogs produced no overt effects on N-MTase activity. The
effect of the purine component of these compounds was also
tested, which resulted in no inhibition.
Several salient features are evident from a pharmacophore
structure-activity-relationship analysis of the inhibitory AdoMetChemistry & Biology 18,analogs (Figure 1B). Common structural features across the
N-MTase inhibitors include a closed backbone configuration
such that the hydroxyl groups of the purine ring are hydrogen-
bonded to the carboxyl oxygen of the amino acid component
and a zwitterionic tail that appears to be required for binding.
Amino acid 50-modifications of these compounds appear to be
tolerated. The three carbon distance between the sulfonium
center and the asymmetric amino acid carbon also appears
to be important for binding, as a reduced length (even by a
single C-linkage) seems to preclude binding, as is the case for
S-adenosyl-L-cysteine.
Docking solutions with a homology model of the N-MTase
domain of module 8 suggest the adenosyl moiety and amino
acid 50-side chain of each analog binds to a similar set of resi-
dues within the AdoMet binding pocket (Figure 1C). The length
of the central Sd (AdoMet, AdoHcy, and AdoEth) or Cd (sinefun-
gin) substituent appears to be the critical structural feature for
differentiating selectivity and binding affinity, as an increase in
substituent length results in steric hindrances with the side
chains of Asn10701 and Met10734 (Figure 1C). The side chains of
Lys10604 and Met10607 are also proximal to the central Sd substit-
uent and may also be involved conferring selectivity. These
residues are largely conserved across all seven N-MTase
domains of CySyn (Velkov and Lawen, 2003a, 2003b). The inhi-
bition of photoaffinity labeling observed in the presence of
various sulfhydryl blocking agents (after loading of the enzyme
with amino acids, in an attempt to avoid preferential alkylation
of the 40-PPant cofactor thiols) also suggests the involvement
of cysteine side-chains in AdoMet binding (Table S2). It follows
that the highest inhibitory activity of AdoHcy results from the
lack of substitution on the central Sd atom. The intermediate
inhibitory activity of sinefungin results from its amino substituted
Cd center, which is similar in size to the Sd methyl of AdoMet.
AdoEth displays a bulky ethyl Sd substituent, and as such,
binding is poorly accommodated.
The Effect of N-MTase Inhibitors on In Vitro Cyclosporin
Biosynthesis
The effects of increasing concentrations of inhibitory AdoMet
analogs on the enzymatic biosynthesis of CsA were examined
(Figure 2A). The complete inhibition of the N-MTase reactions
of CySyn results in the inhibition of CsA biosynthesis. Densito-
metric analysis (not shown) of high performance thin layer chro-
matography (HPTLC) autoradiographs indicated that AdoHcy
was the most potent inhibitor of CsA biosynthesis, followed by
sinefungin and AdoEth, respectively. When the inhibitors were
introduced at a subinhibitory concentration (10 mM), cyclosporin
biosynthesis was preferentially shifted from CsA to cyclosporins
that exhibit five to six N-methylated amides, with the following
abundance: CsURCsL >CsERCsQ>CsA >CsR > >CsT (Fig-
ure S1C). The cyclosporin product profiles observed at 10 mM of
each N-MTase inhibitor were comparable; the data obtained
for the sinefungin reaction are given as an example (Figures
2B–2D). The identity of the cyclosporin products was confirmed
by HPTLC, high performance liquid chromatography (HPLC),
and matrix-assisted laser desorption/ionization time of flight
(MALDI-TOF) mass spectrometry, with reference to authentic
standards calibrated in each analytical method (Figures 2B–
2D). In the control CsA biosynthetic reaction, the main reaction464–475, April 22, 2011 ª2011 Elsevier Ltd All rights reserved 465
Figure 1. Structural Requirements for Cofactor Binding to the N-MTase Centers of CySyn
(A) Chemical structures and IC50 values for S-adenosyl-L-methionine (AdoMet), sinefungin, S-adenosyl-L-homocysteine (AdoHcy) and S-adenosyl-L-ethionine
(AdoEth). The IC50 value for AdoMet reflects its ability to compete with [methyl-
14C]AdoMet and is not indicative of inhibitory activity.
(B) Superimposed energy minimized models of the 3D structures of AdoMet (green), sinefungin (orange), AdoHcy (magenta), AdoEth (blue). Structural moieties
important for binding affinity are highlighted by colored spheres.
(C) Homology model of the N-MTase domain of CySyn module 8 with docking solutions for AdoMet and the aforementioned N-MTase inhibitors.
See also Tables S1 and S2.
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Cyclosporin Synthetase N-Methyltransferase Activitiesproduct is CsA. As by-products, the desmethyl cyclosporins
CsU and CsQ are also observed, with CsA > > CsU > CsQ in
abundance, in agreement with earlier published data (Lawen
et al., 1989). Furthermore, integration of the HPLC traces of the
cyclosporin reaction products synthesized in the presence of
10 mM N-MTase inhibitor indicate an overall lower yield of cyclo-
sporin products, suggesting biosynthesis of cyclosporins with
less than seven N-methyl amides is an unfavored process. This
observation is in line with the frequency and abundance
(compared to CsA) of desmethylated cyclosporins observed
across the 32 cyclosporins isolated from Tolypocladium inflatum
nutrient broths (Lawen, 1996). The desmethyl cyclosporin profile
observed in the presence of subinhibitory concentrations of
N-MTase inhibitors, indicates the enzyme has the ability to466 Chemistry & Biology 18, 464–475, April 22, 2011 ª2011 Elsevier‘‘skip’’ amide N-methylations at certain backbone positions. It
appears that N-methylations are most conserved at positions
3, 9, and 10, whereas unmethylated peptide bonds are most
frequent at positions 1, 4, 6, and 11. However, no more than
two desmethyl positions are tolerated before peptide assembly
stalls, and these will never occur in direct succession.
The Effect of N-MTase Inhibitors on the Partial
Reactions of Peptide Assembly
To examine the possibility that the inhibition of CsA biosynthesis
by the presence of N-MTase inhibitors is due to effects on
adjacent catalytic domains rather than the direct inhibition of
N-MTase, the effect of the N-MTase inhibitors on some of the
individual catalytic activities of A-, PCP-, and C-domains wereLtd All rights reserved
Figure 2. The Effect of N-MTase Inhibitors on
In Vitro Cyclosporin Biosynthesis
(A) Inhibition of CsA biosynthesis by AdoMet analogs. CsA
biosynthesis was monitored in the presence of the indi-
cated concentrations of N-MTase inhibitors. The reaction
products were separated by HPTLC in solvent I and
visualized by autoradiography.
(B) Autoradiograph of the HPTLC separation of reaction
products. Lane 1: Control CsA biosynthetic reaction.
Lane 2: Cyclosporins (Cs) produced in the presence of
10 mM sinefungin. Rf values for Cs reference compounds
are indicated on the ordinate. The running span was 1 3
10 cm in solvent I.
(C) MALDI-TOF analysis of solvent extracted Cs products
synthesized in the absence and presence of 10 mM
sinefungin. The insert table lists the characteristics and
calculated mass for each desmethyl Cs.
(D) Reversed-phase HPLC traces of Cs products synthe-
sized in the absence and presence of 10 mM sinefungin.
The retention a-factor for each Cs is indicated.
See also Figure S1.
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amino adenylation of the substrate amino acid L-leucine, which
is activated by A-domains associated with at least four of the
sevenmodulesharboringN-MTasedomains (Figure 3A).Compa-
rably, there were no effects on the activation of the substrate
amino acid D-alanine, which is activated by the A-domain of the
non-N-MTase initiator module of CySyn (Figure 3A).
The loading of amino acid precursors onto the PCP-domain
as thioesters was not inhibited in the presence of N-MTase
inhibitors (Figure 3B; Table S3). The proportional quantities of
amino acid released in the presence and absence of N-MTase
inhibitors indicates that the covalent attachment of amino acidChemistry & Biology 18, 464–475, April 22substrates L-leucine and L-2-aminobutyric acid
to their respective N-MTase and non-N-MTase
modules remains unaffected in the presence
of N-MTase inhibitors (Figure 3B). For glycine
and L-alanine similar data were obtained (Table
S3). Furthermore, to demonstrate that the
recognition and ATP-dependent carboxyl acti-
vation of each amino acid is mediated by the
A-domain of each respective module, control
incubations for each amino acid were per-
formed in the absence of ATP (Figure 3B, lanes
6 and 12).
The biosynthesis of the diketopiperazine
cyclo-(D-alanyl-L-leucyl) (DKP) partial reaction
product was monitored in the presence of
N-MTase inhibitors. If L-leucine and D-alanine
are the only available amino acid substrates
in an AdoMet-free reaction mixture, the main
reaction product is cyclo-(D-alanyl-L-leucyl),
representing positions 8 and 9 of the CsA mole-
cule. AdoHcy, sinefungin and AdoEth did not
produce any discernible effects on desmethyl-
DKP formation (Figure 3C).
The N-MTase domain physically separates
the PCP from the A-domain (Figure S1B).
Despite its intervening physical positioning,our data indicate that the function of the N-MTase domain is
not critical for the functionality of adjacent A and PCP domains.
Thus, the stalling of CsA biosynthesis with the inhibition of
N-MTase function appears to evolve from a mechanism that op-
erates independently of the fundamental amino acyl-adenylation
and thioester formation reactions.
The Effects of N-MTase Inhibitors on
Peptidyl-S-Intermediate Elongation
To determine the importance of amide N-methylation for the
progression of peptide assembly and the mechanism whereby
N-MTase inhibitors stall CsA biosynthesis, we characterized, 2011 ª2011 Elsevier Ltd All rights reserved 467
Figure 3. The Effect of N-MTase Inhibitors on the Partial Reactions
of Peptide Assembly
(A) The effect of N-MTase inhibitors on the activity of A-domains. The ATP-PPi
exchange rate in the absence of N-MTase inhibitors was set as 100%;
measurements from individual experiments are expressed as relative
percentages of this value.
(B) The effect ofN-MTase inhibitors on the covalent loading of substrate amino
acids as thioesters onto the PCP-domain. Lane 1: [14C]-L-leucine control
reaction, performic acid treatment omitted. Lane 2: Products released after
performic acid treatment of the [14C]-L-leucine control reaction. Lanes 3–5: As
for lane 2 but in the presence of 270 mM L-AdoHcy, sinefungin and L-AdoEth,
respectively. Lane 6: As for lane 2, but excluding ATP. Lane 7: [14C]-L-ami-
nobutyric acid control reaction, performic acid treatment omitted. Lane 8:
Products released after performic acid treatment of the [14C]-L-aminobutyric
acid control reaction Lanes 9–11: As for lane 8 but in the presence of 270 mM
L-AdoHcy, sinefungin and AdoEth, respectively. Lane 12: As for lane 8, but
excluding ATP.
(C) Lane 1: The effect of N-MTase inhibitors on the C-domain peptide bond
condensation reaction. Lane 2: Control CsA biosynthetic reaction. Lane 3:
Control cyclo-(D-alanyl-[14C]-L-leucyl, desmethyl-diketopiperazine biosyn-
thetic reaction. Lane 4: Cyclo-(D-alanyl-[14C]-L-leucyl biosynthetic reaction in
the presence of 270 mM L-AdoHcy. Lane 5: In the presence of 270 mM
sinefungin. Lane 6: In the presence of 270mMAdoEth. Control cyclo-(D-alanyl-
methyl-[14C]-L-leucyl), methyl-diketopiperazine biosynthetic reaction in the
presence of nonlabeled AdoMet.
See also Table S3.
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CsA is assembled via a single linear precursor peptide that is
covalently bound to the modular 40-Ppant-PCP, with chain
elongation occurring by the stepwise trans-peptidation of
the growing peptide chain to the next module for incorporation
of the subsequent activated amino acid in the CsA sequence468 Chemistry & Biology 18, 464–475, April 22, 2011 ª2011 Elsevier(Figure 4A) (Dittmann et al., 1994). The formation of enzyme-
bound linear CsA peptide intermediates was detected by incu-
bating CySyn with all of the components for CsA biosynthesis
and radiolabeled L-leucine. After thioester breakage, the 2–10
residue intermediate peptides of CsA were identified by LC-
ESI-mass spectrometry and high performance 2D thin layer
chromatographic (2D-HPTLC) separation of the products (Fig-
ure 4B; Table S4). CsA chain growth normally occurs to the
undecapeptidyl stage before cyclization and product release.
The final undecapeptide stage in the biosynthesis of CsA was
not detected by 2D-HPTLC, suggesting the linear undecapeptide
is liberated from the enzyme simultaneously with cyclization
and/or the cyclization reaction is very fast. Omission of AdoMet
or the inclusionof saturating levels of an inhibitoryAdoMet analog
from the otherwise complete reaction mixture stops chain
elongation at the D-Ala-L-Leu didpeptidyl stage, observed as
the cyclo-diketopiperazine (Figures 4C and 4D; Table S4). Thus,
N-methylation of amide bonds appears to be critical for linear
chain elongation beyond the two residue stage (cf. Figure 5B).
N-Methylation of Backbone Amides May Preserve
Recognition of the Amino Acyl-S-PCP Acceptor
Nucleophile by Upstream C-Domains
Condensation domains act as the gate-keepers of peptide bond
formation and display rigid substrate selectivity for the incoming
acceptor amino acid, thereby preserving the directionality of
elongation and preventing misinitiation at internal modules
(Belshaw et al., 1999; Doekel and Marahiel, 2000; Ehmann
et al., 2000; Keating et al., 2002; Linne and Marahiel, 2000;
Mootz et al., 2000; Samel et al., 2007; Tanovic et al., 2008).
A widely established mechanism for why nonribosomal peptide
assembly stalls when a tailoring domain is deleted, mutated, or
exchanged into another module is that the upstream C-domain
does not recognize the non-native amino acyl-S-PCP acceptor
nucleophile (Clugston et al., 2003; Linne et al., 2001; Luo et al.,
2001, 2002; Luo and Walsh, 2001; Schauwecker et al., 2000;
Stachelhaus et al., 1998; Stachelhaus and Walsh, 2000; Stein
et al., 2005, 2006). Crystallographic studies have revealed
NRPS C-domains have a V-shaped architecture with a central
canyon-like groove into which the upstream and downstream
PCP-bound condensation substrates can be positioned from
the opposing donor and acceptor sites, respectively (Keating
et al., 2002; Samel et al., 2007; Tanovic et al., 2008) (Figure 5A).
In the PCP-C di-domain structure of TycC5-C6, the A/H
conformation (Koglin et al., 2006; Weber et al., 2000) of the
PCP domain interacts with the C-domain donor site in a catalyt-
ically un-productive orientation for peptide bond formation
(Samel et al., 2007). Whereas, in the structure of the termination
module of SrfA (Tanovic et al., 2008), the A/H conformation of the
PCP is stalled in the C-domain acceptor site with its 40-PPant
binding site situated 16 A˚ away from the HHxxxDG core catalytic
motif (Bergendahl et al., 2002; Stachelhaus et al., 1998), indica-
tive of a catalytically productive orientation. We have modeled
the C-domain of module 2 of CySyn (where CsA elongation
stalls) with the upstream (donor) and downstream (acceptor)
PCP domains (in the A/H state), and docked them into their
respective C-domain donor and acceptor sites according to
the productive PCP-C-domain contacts defined bymutagenesis
studies (Finking et al., 2004; Lai et al., 2006a, 2006b), and seen inLtd All rights reserved
Figure 4. The Effects of N-MTase Inhibitors on Peptidyl-S-Interme-
diate Elongation
(A) Linear peptidyl-S-enzyme intermediate stages in CsA biosynthesis. M1 to
M11 represent the CySyn modular units responsible for binding and incor-
poration of individual amino acid components of CsA (cognate amino acid
substrates are indicated to the left of each module).
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Chemistry & Biology 18,the SrfA termination module structure (Tanovic et al., 2008). The
docking solutions with the 40-PPant donor and acceptor
substrates suggest one of the mechanisms that stall CsA
assembly at the dipeptidyl stage on N-MTase inhibition or
absence of AdoMet is the inability of the acceptor site of the
C-domain of module 2 to recognize the unnatural desmethyl
Leu3-S-PCP acceptor (Figure 5). The C-domain acceptor
channel is formed by secondary elements aC1 and aC10. The
side chains of Leu1124, Trp1136, Tyr1137, Ile1244, Phe1399 form a
hydrophobic pocket surrounding the catalytic HHxxxDG core
that cradles the methylated amide of the MeLeu3-S-PCP
acceptor (Figure 5A). These residues are largely conserved
across all of the C-domains of CySyn (Velkov and Lawen,
2003b), with the exception of Phe1399, which is substituted by
Cys or Pro only in the non-N-MTase modules 1, 6, 9, and 11.
In the methyl-substrate acceptor site model, the side chain of
Phe1399 makes hydrophobic contacts with the methyl amide of
the MeLeu3-S-PCP acceptor. Whereas, in the corresponding
desmethyl-substrate acceptor site model, the polar amide of
Leu3-S-PCP is poorly accommodated by the Phe1399 side chain
and orientated away from the catalytic HHxxxDG. The docking
solution for the donor site model suggests the D-Ala1-MeLeu2
dipeptidyl-S-PCP approaches the HHxxxDG core from the
opposing face of the channel formed by aC5, aC6, and aC9. In
light of the nondiscriminatory nature of the donor site, it is not
surprising that the residues forming the donor channel are
conserved across all C-domains of CySyn (Velkov and Lawen,
2003b).
Desmethylation Affects Cyclosporin Backbone
Conformation and Intramolecular Hydrogen Bonding
CsA and the partially unmethylated congeners CsE, CsQ, CsU,
and CsT were studied by 1D and 2D 1H-nuclear magnetic reso-
nance (NMR) spectroscopy with the focus on the effect of des-
methylation on backbone conformation and intrachain hydrogen
bonding (Figure 6A; Figures S2 and S3). The amide region of the 1
H-NMR spectra of each cyclosporin in CDCl3 is shown in Fig-
ure 6A. An examination of the amide signals shows CsA and
CsE exhibit one major conformer in CDCl3, indicated by a domi-
nant set of signals for each amide proton, whereas CsU, CsQ,
and CsT all display >10 major peaks indicating the presence of
at least two slowly interconverting conformations (Figure 6A).
The 1H assignment of CsA, CsE, and CsU in CDCl3 at 298.15 K
was determined by means of standard homonuclear 2D experi-
ments (DQF-COSY, ROESY, and TOCSY) (Figure S3 and Table
S5). The spectra for CsQ and CsT could not be assigned under
these conditions due to the existence of multiple interchanging
conformers. A comparison of the Ca proton shifts of the des-
methyl cyclosporins to CsA indicates significant conformational
differences in the loop region over residues 6 and 4 and the anti-
parallel b-pleated sheet over residues 4–10, suggesting the
preferred conformation of the desmethyl congeners differ from(B–D) Autoradiographs of 2D-HPTLC chromatograms of CsA peptide inter-
mediates after performic acid liberation. (B) Peptides released from the unin-
hibited control CsA biosynthetic reaction, identified by numbering as per
Figure 4A, (C) in the absence of AdoMet, (D) in the presence of AdoMet and
1 mM sinefungin.
See also Table S4.
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Figure 5. Modeling the Recognition of Donor and Acceptor Intermediates by the C-Domain of Module 2
(A) Tentative C-domain model of CySyn module 2 with the upstream (donor) and downstream (acceptor) PCP domain substrates docked into their respective
C-domain donor and acceptor sites.
(B) Schematic diagram of the catalytic events depicted in the C-domain model.
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Cyclosporin Synthetase N-Methyltransferase Activitiesthat of CsA (Table S5). The largest chemical shift differences are
for the Ca-protons of MeBmt
1 and Val11 in CsE, and the Ca-
protons of MeLeu6 in CsE, and Leu6 in CsU.
To verify the involvement of the free amide protons in
hydrogen bonding, we examined the temperature dependence
of their chemical shifts in the 25–45C range (Figure 6B).
A temperature coefficient of less than 4.5 ppb/K, indicates
the involvement in hydrogen bonding (Stevens et al., 1980).
However, it must be noted that in the case of cyclic peptides,
small temperature dependencies can also be observed if the
NH group is shielded from the solvent and remains shielded
over the temperature range of the 1H-NMR experiment (Stevens
et al., 1980). The plot of dNH versus T (K) for CsA indicates the four
exchangeable protons display a linear dependence on tempera-
ture, the rates of shift for the NH groups agree with their partici-
pation in hydrogen bonds:3.6 ppb/K (Abu2);3.7 ppb/K (Ala7);
1.8 ppb/K (Val5); 1.1 ppb/K (D-Ala8). The rates of shift for
the NH groups for CsE also agreed with their participation in
stable hydrogen bonds: 2.9 ppb/K (Abu2); 1.6 ppb/K (Ala7);
1.7 ppb/K (Val5); 2.7 ppb/K (D-Ala8); 2.5 ppb/K (Val11).
The small temperature gradient for the additional free NH at
the Val11 desmethyl position of CsE suggests it is involved in
stable hydrogen bonding. The occurrence of one additional470 Chemistry & Biology 18, 464–475, April 22, 2011 ª2011 Elsevierintrachain hydrogen bondwas also observed in the crystal struc-
ture of CsE (Husa´k et al., 1998). The temperature dependence
data for CsU indicate that the NH groups of Ala7 (2.8 ppb/K),
Val5 (1.4 ppb/K), and D-Ala8 (2.0 ppb/K) are involved in stable
hydrogen bonds. The faster rate of shift for Abu2 (4.1 ppb/K)
and the additional desmethyl position Leu6 (4.0 ppb/K) suggest
that the hydrogen bonds of these groups are markedly weaker.
A large temperature dependence is known to occur when a
NH, is initially shielded through intramolecular hydrogen bonding
and becomes transferred into a solvated environment with
increasing temperature (Stevens et al., 1980). We interpret the
large temperature dependence of the Abu2 and Leu6 NH amides
in CsU as indicating the presence of intramolecularly hydrogen
bonded NH amides that are thermally disrupted over the temper-
ature range of the 1H-NMR experiment.
Collectively the NMR data indicate that desmethylation at
even a single amide position significantly affects the hydrogen
bonding and backbone conformation of cyclosporins. In CsA
the backbone is constrained by N-methylation of specific amide
bonds that limits the hydrogen bonding potential. Removal of an
N-methyl from position eleven as in CsE (MeVal11/Val11) results
in changes over the loop region formed by residues 6–11with the
formation of a hydrogen bond Ala7-CO—HN-Val11 (Figure 6C).Ltd All rights reserved
Figure 6. NMR Characterization of the Effect of
Desmethylation on Cyclosporin Backbone Confor-
mation and Intramolecular Hydrogen Bonding
(A) Amide proton region of the 1H NMR spectra in (Fig-
ure S2).
(B) Plots of the chemical shift variation as a function of
temperature for amide protons, the temperature coeffi-
cients were obtained by linear regression fitting of the data
points (solid line).
(C) Inferred backbone hydrogen bonding pattern of CsA
and the desmethyl congeners, CsE and CsU.
See also Figures S2 and S3, and Table S5.
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Cyclosporin Synthetase N-Methyltransferase ActivitiesSimilarly, in CsU the loss of the position 6 amide N-methyl group
(MeLeu 6/Leu6) allows for the formation of an additional
hydrogen bond MeBmt1-CO—HN-Leu6 (Figure 6C).
N-Methylation of Backbone Amides May Facilitate
Preorganization of the Peptide for Cyclization
The total chemical synthesis of CsA and its precursors is
complex (Wenger, 1984), and limited by the lack of commercial
availability and the difficulty to synthesize the amino acid Bmt
(Savignac et al., 1994). To overcome these limitations, we used
molecular modeling to examine the effects of N-methylation
patterns on backbone conformer preferences of linear CsA pep-
tidyl-S-enzyme intermediates. Molecular models of the 3–11
amino acid stages of fullyN-methylated and desmethyl CsA pep-
tidyl-S-enzyme intermediates were constructed (Figure S4). TheChemistry & Biology 18, 464–475, April 22models suggest that the specific set of amide
N-methylations present in CsA is critical at the
five residue peptidyl-S-enzyme intermediate
stage. The simulation predicts that the des-
methyl backbone folds in on itself into a tight
cyclic structure with the termini almost in
contact. In comparison, the fully N-methylated
form is more open and elongated because the
four consecutive amide N-methylations over
the loop region formed by the first four residues,
act to prevent the structure from closing up on
itself before elongation is complete. Over the
6–11 residue stages, each desmethyl peptide
is predicted to cyclize back onto itself toward
the carboxyl termini anchor point on the enzyme
PCP-40-Ppant, with both termini too close
together, which would possibly interfere with
elongation. This results from extensive intramo-
lecular hydrogen bonding. In comparison, over
the 6–11 residue stages of the fully N-methyl-
ated backbone, the intermediates adopt a
product-like conformation via the formation of
the ordered succession of hydrogen bonds
seen in the CsA structure (Figure S1A and
Figure S4). These include hydrogen bonds
between, Abu2-CO—HN-Val5 at the nine
residue intermediate stage, then at the 10
residue intermediate stage between the Val5-
CO—HN-Abu2, and finally at the mature length
11 residue stage between MeVal11-CO—HN-Ala7, and MeLeu6-CO—HN- D-Ala8 (Figure 6C; Figure S1A).
The latter hydrogen-bond serves to hold the backbone in a folded
L-shape. The fully N-methylated peptidyl-S-enzyme intermedi-
ates fold back toward the protein anchor point but with the
free amino terminus end folding from above the anchor point,
so as not to interfere with the assembly process.
Overall the modeling data suggest that the amide N-methyla-
tion pattern of CsA only allows for specific intrachain hydrogen
bonds that may operate to stabilize the open undecapeptide
chain into a product-like conformation, thereby bringing the
amino and carboxyl termini of position 7 and 8 together to assist
cyclization. Preorganization of the growing peptidyl-S-interme-
diate into a product-like conformation is an emerging consensus
mechanism across NRPS systems (Kohli et al., 2001, 2002;
Trauger et al., 2000, 2001; Tseng et al., 2002). It appears, 2011 ª2011 Elsevier Ltd All rights reserved 471
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during assembly such as amide N-methylation help maintain
the growing peptide in a product-like conformation that ensures
that trans-peptidation and cyclization reactions proceed
un-hindered by futile intramolecular bonding events. In the
assembly of the peptide tyrocidine A, the peptide substrate is
preorganized for cyclization via intramolecular backbone
hydrogen bonds similar to those in the product to allow for
the proper presentation of the termini to the thioesterase
domain for ring closure (Kohli et al., 2001, 2002). The overall
rate of product cyclization/release was shown to be dependent
on the rate of substrate pre-organization (Kohli et al., 2001, 2002).
Structural modifications such as N-methylation that inhibit
backbone hydrogen bonding are, therefore, likely to influence
the pre-organization of the peptide backbone for cyclization.
Thus, the slower rate of biosynthesis of cyclosporins with five
to six backbone N-methylations may be attributable to a less
facile preorganization rate. Coincidentally, N-methylation of a
specific amide bond position was shown to be mandatory for
a high substrate turnover in the biosynthesis of streptogramin B
antibiotics (Mahlert et al., 2005). In the biosynthesis of tyrocidine
A, key residues near the N- and C-termini are involved in the
formation of intramolecular hydrogen bonds to allow for preorga-
nization of the linear peptide backbone, such that the N- and
C-termini are presented in the correct orientation for macrocycli-
zation (Trauger et al., 2001). In the CsA structure, the hydrogen
bond between the amide nitrogen of D-Ala8 and the carbonyl
oxygen of L-Ala7 helps to bring the ends of the molecule together
for cyclization. The small side chains of the N- and C-terminal
alanine residues of CsA also facilitate cyclization by allowing
the ends to come close together into a suitable orientation for
condensation. The D-configuration of the C-terminal alanine
facilitates ring formation over side reactions as has been shown
with other examples in the literature (Brady et al., 1979). This is
coincident with the strict selectivity of the A-domain of the last
module incorporating for an L-amino acid and the strict D-chiral
selectivity of the first A-domain module incorporating D-Ala8
(Lawen and Traber, 1993). Similarly, N- and C-terminal amino
acid side-chain stereochemistry and size constraints appear to
be in place for other non-ribosomal peptide cyclization reactions
(Tseng et al., 2002). Wenger (1984) described the first total
synthesis of the CsA molecule using a fragment-condensation
technique. Chemical cyclization of the synthetic undecapeptide
between positions 7 and 8, analogous to the enzymatic cycliza-
tion reaction, was the most efficient route. Moreover, L-Ala7
and D-Ala8 are the only consecutive pair of N-desmethyl amino
acids in the CsA molecule. This further facilitates ring closure,
as chemical amide bond formation betweenN-methylated amino
acid residues is more difficult (Gund and Veber, 1979; Nitecki
et al., 1968). Additional structural features of the CsA molecule
that facilitate the reorganizational folding process include the
presence of the invariant N-methyl glycine (sarcosine) in the
middle of the open peptide that serves as a b-turn forming
element. A b sheet appears to be a critical substructure requisite
for proper preorganization for cyclization and release of nonribo-
somal peptides (Trauger et al., 2000, 2001). Accordingly, back-
bone N-methylation is crucial for conservation of the proper
hydrogen bonding pattern that preserves this b sheet structure
of CsA.472 Chemistry & Biology 18, 464–475, April 22, 2011 ª2011 ElsevierSIGNIFICANCE
The N-methylation of enzyme-bound intermediates is of
general importance in the synthesis of many peptide and
depsipeptide antibiotics. In future, it is hoped thatN-methyl-
transferase tailoring functions can be routinely exploited
in the genetic engineering of hybrid synthetases for the
rational design of peptide antibiotics. These new biosyn-
thetic approaches require detailed studies into the enzy-
mology of the reactions involved and the effect of these
modifications have on active conformation of the cyclic
peptide. This study indicates N-methylation of specific
amide positions in the backbone of CsA is critical for the
efficient progression of peptide assembly to the mature
undecapeptidyl stage. The desmethylation of even a single
amide appears to destabilize the main conformation of
CsA. Given the mechanistic similarities across NRPS, these
findings provide a biochemical model for N-methylation
processes of NRPS in general.EXPERIMENTAL PROCEDURES
Materials
S-adenosyl-L-[methyl-14C]methionine ([14C-methyl]AdoMet, 58 Ci/mol), [14C]-
iodoacetamide (21 mCi/mmol), and [14C]-L-leucine ([14C]-L-Leu, 30 mCi/mmol)
were purchased from New England Nuclear (Boston, MA). (4R)-4-[(E)-2-butyl]-
4-methyl-L-threonine (Bmt) and the cyclosporin standardswere kindly donated
by Dr. R. Traber (Novartis Ltd., Basel, Switzerland) and Dr. A. Jegerov (Galena
Co. Ltd., Czech Republic). AdoMet and analogs were purchased from Sigma
(Castle Hill, NSW, Australia). Sinefungin was a generous gift from Eli Lilly
Research Laboratories (Indianapolis, IN).
Growth of Tolypocladium inflatum and Purification of CySyn
These methods were performed as previously described (Velkov et al., 2006).
Assay of N-MTase activity
N-MTase activity was assayed by monitoring the incorporation of [14C]-methyl
groups from S-adenosyl-L-[methyl-14C]methionine into the amide nitrogens of
CsA, according to Lawen et al. (1989) and Lawen and Zocher (1990). Where
indicated in the results, the assay mixture was supplemented with an AdoMet
analog dissolved in buffer A (0.1 M Tris, pH 7.8; 4 mM EDTA; 4 mM dithiothrei-
tol; 15% (v/v) glycerol).
Photoaffinity Labeling of CySyn with [14C-methyl]AdoMet
These methods were performed as previously described (Lawen and Zocher,
1990; Velkov and Lawen, 2003a).
Liberation of Covalently Bound Amino Acids and Linear Peptide
Intermediates
The release and development of covalently-bound peptide intermediates from
CySyn was performed as previously described (Dittmann et al., 1994). Two-
dimensional HPTLC analysis of isolated peptidyl-intermediates was per-
formed as previously described (Dittmann et al., 1994). Peptide spots were
visualized by superimposition of autoradiographs from 2D-HPTLC analysis
of [14C]-L-leucine radiolabeled biosynthetic reactions. Peptides were identified
by liquid chromatography electrospray ionization mass spectrometry (LC ESI-
MS). The measurement of thioester formation was as previously described
(Dittmann et al., 1990, 1994).
Assay of Amino Acid Adenylation (Substrate Amino Acid-Dependent
ATP-32PPi Exchange Activity)
The quantification of the aminoacyl adenylation of the amino acid substrates
was performed by the ATP-PPi exchange method (Linne and Marahiel, 2004).Ltd All rights reserved
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Diketopiperazines
The enzymatic biosynthesis of cyclosporins and cyclo-(D-Ala-L-Leu) diketopi-
perazine was monitored by the incorporation of [14C]-L-leucine as previously
described (Dittmann et al., 1990).
HPTLC
HPTLC of cyclosporins and cyclo-(D-Ala-L-Leu) diketopiperazines was per-
formed on silica gel sheets (Merck, Darmstadt, FGR) developed with water-
saturated ethyl acetate (EtOAc) (solvent I). Radiolabeled material was visual-
ized by autoradiography and superimposed onto iodine vapor stained HPTLC
plates and correlated with bona fide reference compounds. Radioactive amino
and N-methyl amino acids released from the enzyme after performic acid
hydrolysis were separated on silica plates developed in butanol/acetic acid/
H2O (4:1:1) (solvent II).
HPLC Analysis of In Vitro Cyclosporin Products
Cyclosporin products were concentrated by SpeedVac centrifuge and resus-
pended in 20 ml acetonitrile (ACN)/H2O (60:40). Reverse phase HPLC of cyclo-
sporins was performed on a Zorbax 300 A˚ column (C18, 3.5 mm, 4.63 250 mm)
(Agilent Technologies, Melbourne Victoria, Australia). Separation was per-
formed isocratically at 75C with ACN/H2O/H3PO4 (630:370:0.1) as the mobile
phase, at a flow rate of 1 ml/min, cyclosporins were detected at 210 nm. The
identity of enzymatic cyclosporin products was ascertained by reference to the
retention a-factor of bona fide reference compounds and MALDI-TOF MS
analysis of individual peak fractions. The a-factor is defined as the relative
retention time [(tR,1 to)/(tR,2 to)]3 10 where tR,1 and tR,2 are the correspond-
ing retention times and to is the dead retention time of the column. CsA is taken
as the reference compound and assigned as a = 10.
MALDI-TOF mass spectrometry
The positive ion MALDI-TOF mass spectra were recorded on a MALDI
VOYAGER DE STR time of flight mass spectrometer (PerSeptive Biosystems,
Framingham MA). The ion acceleration voltage was set at 20 kV. Samples
were irradiated with a pulsed nitrogen laser at 337 nm. When delayed extrac-
tion was used, a potential difference between the probe and extraction
lens was applied at a time delay of 300 ns subsequent to each laser pulse.
For the MALDI matrix, a solution of saturated a-cyano-hydroxy-cinnamic
acid in 50% ACN (v/v)/0.1% trifluoroacetic acid (TFA) (v/v) in H2O was
employed. Samples were applied onto the MALDI probe by the dried-drop
method: 1 ml matrix solution was spotted directly onto the plate and allowed
to air dry at room temperature, followed by 1 ml of sample, and dried at
room temperature.
NMR Methods
Cyclosporin 1H-NMR spectra were assigned by standard sequential assign-
ment methods (Wu¨thrich, 1986). NMR spectra were collected on a Varian
INOVA 600 MHz spectrometer equipped with a cryogenically cooled
triple-resonance probe at 25C in deuterated CDCl3. The chemical shifts
were referenced relative to the solvent peak and tetramethylsilane set to
0.0 ppm. Data were processed with NMRPipe software and analyzed in
SPARKY.
Molecular Modeling
Molecular modeling operations for linear CsA intermediates were performed
using the Accelrys Discovery Studio V2.1 using previously described methods
(O’Donohue et al., 1995). Initial CsA coordinates were extracted from the
Cambridge Crystallographic databank (access code: DEKSAN). A structural
model of the AdoMet binding site of the N-MTase domain of module 8 of
CySyn was constructed using the crystallographic structure of catechol-O-
methyltransferase (RCSB PBD: 1VID) as the modeling template (Velkov and
Lawen, 2003a). A homology model of the C-domain of module 2 and PCP
domains of modules 2 and 3 were constructed using the 1.8 A˚ crystallographic
structure of the C-domain of tyrocidine synthetase (RCSB PBD: 2JGP) (Samel
et al., 2007) and termination module of SrfA-C (RCSB PBD: 2VSQ) (Tanovic
et al., 2008) as the templates. All modeling and docking operations were
performed with Accelrys Discovery Studio V2.1.Chemistry & Biology 18,SUPPLEMENTAL INFORMATION
Supplemental Information includes four figures and five tables and can be
found with this article online at doi:10.1016/j.chembiol.2011.01.017.
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